chr6-32968658-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_005104.4(BRD2):c.-1703C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 153,654 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.024 ( 63 hom., cov: 33)
Exomes 𝑓: 0.033 ( 0 hom. )
Consequence
BRD2
NM_005104.4 5_prime_UTR
NM_005104.4 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0370
Publications
2 publications found
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
HLA-DMA (HGNC:4934): (major histocompatibility complex, class II, DM alpha) HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0237 (3603/152316) while in subpopulation SAS AF = 0.039 (188/4824). AF 95% confidence interval is 0.0344. There are 63 homozygotes in GnomAd4. There are 1726 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0237 AC: 3603AN: 152198Hom.: 63 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3603
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0329 AC: 44AN: 1338Hom.: 0 Cov.: 0 AF XY: 0.0359 AC XY: 37AN XY: 1030 show subpopulations
GnomAD4 exome
AF:
AC:
44
AN:
1338
Hom.:
Cov.:
0
AF XY:
AC XY:
37
AN XY:
1030
show subpopulations
African (AFR)
AF:
AC:
1
AN:
26
American (AMR)
AF:
AC:
0
AN:
8
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
1
AN:
32
South Asian (SAS)
AF:
AC:
10
AN:
306
European-Finnish (FIN)
AF:
AC:
0
AN:
20
Middle Eastern (MID)
AF:
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
AC:
30
AN:
890
Other (OTH)
AF:
AC:
2
AN:
42
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0237 AC: 3603AN: 152316Hom.: 63 Cov.: 33 AF XY: 0.0232 AC XY: 1726AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
3603
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
1726
AN XY:
74474
show subpopulations
African (AFR)
AF:
AC:
269
AN:
41578
American (AMR)
AF:
AC:
374
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
40
AN:
3472
East Asian (EAS)
AF:
AC:
124
AN:
5170
South Asian (SAS)
AF:
AC:
188
AN:
4824
European-Finnish (FIN)
AF:
AC:
150
AN:
10616
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2389
AN:
68024
Other (OTH)
AF:
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
185
370
556
741
926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
169
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.